Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2009 2
2010 4
2011 5
2012 4
2013 5
2014 2
2015 5
2016 1
2017 3
2018 5
2019 3
2020 3
2021 2
2022 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
McDermott DF, Huseni MA, Atkins MB, Motzer RJ, Rini BI, Escudier B, Fong L, Joseph RW, Pal SK, Reeves JA, Sznol M, Hainsworth J, Rathmell WK, Stadler WM, Hutson T, Gore ME, Ravaud A, Bracarda S, Suárez C, Danielli R, Gruenwald V, Choueiri TK, Nickles D, Jhunjhunwala S, Piault-Louis E, Thobhani A, Qiu J, Chen DS, Hegde PS, Schiff C, Fine GD, Powles T. McDermott DF, et al. Among authors: danielli r. Nat Med. 2018 Jun;24(6):749-757. doi: 10.1038/s41591-018-0053-3. Epub 2018 Jun 4. Nat Med. 2018. PMID: 29867230 Free PMC article. Clinical Trial.
Immunotherapy targeting immune check-point(s) in brain metastases.
Di Giacomo AM, Valente M, Covre A, Danielli R, Maio M. Di Giacomo AM, et al. Among authors: danielli r. Cytokine Growth Factor Rev. 2017 Aug;36:33-38. doi: 10.1016/j.cytogfr.2017.07.002. Epub 2017 Jul 13. Cytokine Growth Factor Rev. 2017. PMID: 28736183 Review.
False Leser-Trélat sign.
Rubegni P, Mandato F, Mourmouras V, Danielli R, Fimiani M. Rubegni P, et al. Among authors: danielli r. Int J Dermatol. 2009 Aug;48(8):912-3. doi: 10.1111/j.1365-4632.2009.04113.x. Int J Dermatol. 2009. PMID: 19659878 No abstract available.
Armed antibodies for cancer treatment: a promising tool in a changing era.
Danielli R, Patuzzo R, Ruffini PA, Maurichi A, Giovannoni L, Elia G, Neri D, Santinami M. Danielli R, et al. Cancer Immunol Immunother. 2015 Jan;64(1):113-21. doi: 10.1007/s00262-014-1621-0. Epub 2014 Oct 15. Cancer Immunol Immunother. 2015. PMID: 25314912 Free PMC article. Review.
Eruptive porokeratosis under nivolumab adjuvant treatment for melanoma.
Cinotti E, Fiorani D, Provvidenziale L, Miracco C, Calamai V, Danielli R, Rubegni P. Cinotti E, et al. Among authors: danielli r. Int J Dermatol. 2019 Jul;58(7):e138-e140. doi: 10.1111/ijd.14415. Epub 2019 Feb 27. Int J Dermatol. 2019. PMID: 30810218 No abstract available.
41 results